Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 12 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Feb 25, 2025
Last action: May 5, 2025 — Committee report sent to Calendars
Session: 89R
Momentum: 62 · High

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 19%, measured from TX's completed sessions
Momentum +3 62/100 from the pace of recorded action
Time since last action -22 529 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.